Results 11 to 20 of about 58,375 (292)

Peptide receptor radionuclide therapy [PDF]

Best Practice & Research Clinical Gastroenterology, 2005
Peptide receptor radionuclide therapy is a new treatment modality for patients with inoperable or metastasised neuroendocrine gastroenteropancreatic tumours.
Esser, J.-P. (Jan-Paul), Jong, M. (Marcel) de, Krenning, E.P. (Eric), Kwekkeboom, D.J. (Dirk Jan), Teunissen, J.J.M. (Jaap), Valkema, R. (Roelf)   +5 more
core   +7 more sources

Radionuclide therapy [PDF]

Radiographer, 2011
AbstractThis article follows the article An Introduction to Nuclear Medicine published in this issue of The Radiographer. Nuclear medicine is the injection, ingestion or inhalation of a radiopharmaceutical for the purpose of diagnosis or therapy. While the previous article focussed on the fundamental principles of diagnostic imaging, this paper focuses
JM Wheat, GM Currie, R Davidson, H Kiat
  +4 more sources

Targeted Radionuclide Therapy [PDF]

Cancers, 2011
Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of biological vectors and appropriate radionuclides. Among the many advantages of this approach are its selectiveness in delivering the radiation to the target, relatively less severe and infrequent side effects, and the
Ersahin, Devrim, Doddamane, Indukala, Cheng, David   +2 more
openaire   +2 more sources

Radioprotective Effect of Beta D-Glucan and Vitamin E on Gamma Irradiated Mouse [PDF]

Journal of Clinical and Diagnostic Research, 2017
Introduction: It is shown that beta-D-glucan is an immunologic system booster with radioprotectory effects. Radioprotectors are chemical components that can alleviate biological damage produced by ionizing radiation.
Faraj Tabeie, Seyed Mehdi Tabatabaei, Ali Mahmoud-Pashazadeh, Majid Assadi   +3 more
doaj   +1 more source

Theragnostic Radionuclide Pairs for Prostate Cancer Management: ⁶⁴Cu/⁶⁷Cu, Can Be a Budding Hot Duo

Biomedicines, 2022
Prostate cancer (PCa) is one of the preeminent causes of mortality in men worldwide. Theragnostic, a combination of therapy and diagnostic, using radionuclide pairs to diagnose and treat disease, has been shown to be a promising approach for combating ...
Anupriya Chhabra, Mathew L. Thakur
doaj   +1 more source

Management of biological waste of patients after radionuclide therapy

Радиационная гигиена, 2022
Radioactive waste management is a modern-day issue in terms of radiation safety due to the development of radionuclide therapy, the emergence of new radiopharmaceuticals, radionuclides, and treatment methods, which allow for radionuclide therapy in a day
L. A. Chipiga, A. V. Vodovatov, I. A. Zvonova, A. A. Stanzhevsky, A. V. Petryakova, E. E. Anokina, K. S. Velichkina, S. A. Ryzhov   +7 more
doaj   +1 more source

Hybrid Single-Photon Emission Computed Tomography/Computed Tomography Imaging Features of Tumoral Calcinosis in Technetium-99m Methylene Diphosphonate Bone Scintigraphy

World Journal of Nuclear Medicine, 2015
Tumoral calcinosis (TC) is an uncommon ectopic calcification syndrome. TC is a benign condition characterized by the presence of large calcific soft tissue deposits occurring predominantly in a periarticular location.
Koramadai Kamaleshwaran, Premkumar Asokumar, Anjali Malaikkal, Vyshakh Mohanan, Ajit Shinto   +4 more
doaj   +1 more source

Radionuclides for Targeted Therapy: Physical Properties

Molecules, 2022
A search in PubMed revealed that 72 radionuclides have been considered for molecular or functional targeted radionuclide therapy. As radionuclide therapies increase in number and variations, it is important to understand the role of the radionuclide and ...
Caroline Stokke, Monika Kvassheim, Johan Blakkisrud   +2 more
doaj   +1 more source

Fluroine-18 fluorodeoxyglucose-positron emission tomography/computer tomography in staging of renal cell carcinoma arising from a native kidney with liver and bone metastasis in a renal transplant patient

World Journal of Nuclear Medicine, 2018
Renal cell carcinoma (RCC) of the native kidney accounts for
Koramadai Kamaleshwaran, Bharat Rangarajan, Raghi Jose, Ajit Shinto   +3 more
doaj   +1 more source

First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer

Journal for ImmunoTherapy of Cancer, 2022
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy is a validated treatment option for patients with advanced prostate cancer. Although PSMA expression is not limited to prostate tissue, little is known about its relevance to other ...
John Prior, Solange Peters, Krisztian Homicsko, Sarah Boughdad, Niklaus Schaefer, Antonia Digklia, Clarisse Dromain, Mounir Trimech, Ana Dolcan   +8 more
doaj   +1 more source